Morgan’s Stocks 2026: Halftime Review Hits Key Lanes
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
Wondering which is better: cash back or points credit card? Explore the pros and cons to choose the right card for your needs.
27,103 articlesAt midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
When a venerable logistics giant trades near the $120 mark, investors debate more than price. This guide weighs the u...
In 2026, Nike faces a pivotal test beyond revenue growth. This article explains why nike's most important question ce...
Newmont released after-hours results, signaling steady production yet revenue depends on gold prices. The company gui...
The spotlight isn’t only on SCHD. Schwab’s international dividend ETF SCHY is quietly stealing the show for investors...
NuScale Power trades on potential milestones and financing clarity. This guide explains why investors may consider ca...
Analysts warn that the stock market’s double bubble could burst if corporate earnings fail to keep pace with lofty pr...
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...
Greg Abel, stepping into Warren Buffett's shadow, has quietly tripled Berkshire's Alphabet stake. Is this the kind of...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Looking for nasdaq stocks before they soar in 2026? This article uncovers two compelling growth names, the catalysts ...